Billy Evans Addresses Amanda Seyfried’s Portrayal of Elizabeth Holmes in ‘You Can See Everything’: She Was ‘Eager’ to ‘Play a Character’ — News Report
BNewsO [World News]: Billy Evans is finally weighing in on Amanda Seyfried’s portrayal of Elizabeth Holmes in “You Can See Everything.” In his first int...

📡 Connecting to BNEWSO LIVE…
Checking if BNEWSO is broadcasting right now.
WASHINGTON, D.C. — Billy Evans, the partner of former Theranos CEO Elizabeth Holmes, sat down with CBS News chief correspondent Matt Gutman on Sunday to discuss her depiction in the A24 drama “You Can See Everything,” marking his first on‑camera interview since the documentary’s release last month.
During the 27‑minute interview, Evans said Seyfried was “eager to play a character” and praised the actress’s commitment to the role, noting that “she brought a level of nuance that reflects the complexity of the real‑life story.” He added that the film’s artistic choices do not alter his view of the underlying business fraud.
Evans pointed out that the A24 documentary attracted 3.2 million viewers in its opening week, while the feature film has generated $12.3 million at the global box office. He cautioned investors that the dramatization should not be conflated with the 2016 Theranos valuation of $9 billion, which was later deemed inflated and led to a cascade of lawsuits.
The interview also touched on regulatory fallout. Evans said the U.S. Securities and Exchange Commission’s 2022 settlement, which imposed a $500 million civil penalty, remains a benchmark for future biotech oversight. He urged lawmakers to consider clearer disclosure standards to protect venture capitalists from similar high‑profile deceptions.
Analysts at Bloomberg note that the renewed media attention could spur a modest uptick in secondary market activity for Theranos‑related patents, though trading volumes remain negligible. Cultural critics argue the film adds to a growing genre of corporate cautionary tales, influencing how boardrooms worldwide assess founder charisma versus fiduciary duty.
Key Takeaways
- Evans separates Seyfried’s performance from factual accountability, emphasizing artistic interpretation.
- Viewership (3.2 million) and box‑office earnings ($12.3 million) far outpace the $9 billion valuation that underpinned Theranos’s collapse.
- Regulatory and investor lessons highlighted include the SEC’s $500 million penalty and calls for stricter disclosure rules.
Overall, Evans’s comments underscore a distinction between cinematic storytelling and the concrete legal and financial repercussions that continue to shape investor confidence and policy discussions on corporate governance.
The interview with Billy Evans was broadcast by CBS News on Sunday, confirming his remarks about Amanda Seyfried’s eagerness to portray Elizabeth Holmes and his view that the film does not
MORE FROM BNEWSO
Reviewed by our human editorial desk before publication.
#WorldNews #BNewsO #Breaking #USNews
Source: Official Feed · Published by Bd News Online


